Literature DB >> 532796

Effects of ibuprofen, tolmetin and placebo on the gastric mucosa of aspirin-sensitive volunteers.

F L Lanza, R S Nelson, G L Royer.   

Abstract

Patients who have demonstrated a gastric mucosal sensitivity to aspirin often react to other nonsteroidal, anti-inflammatory drugs to a similar or lesser degree. In a single-blind crossover study, five healthy volunteers who had previously developed erosive gastritis secondary to one week of aspirin therapy were randomly assigned to seven-day courses of treatment with ibuprofen, tolmetin and placebo. Treatment schedules were separated by washout periods to eliminate residual drug effects. Ibuprofen produced less gastric mucosal injury than tolmetin and, over all, appeared to be better tolerated. It was also noted that clinical symptoms often do not reflect the severity of gastroscopic findings, which may explain silent hemorrhaging in patients treated with agents of this type.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 532796

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  4 in total

1.  A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects.

Authors:  F L Lanza
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

Review 2.  Non-steroidal anti-inflammatory drugs. Current status and rational therapeutic use.

Authors:  F D Hart; E C Huskisson
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546

3.  Effect of acetaminophen on human gastric mucosal injury caused by ibuprofen.

Authors:  F L Lanza; G L Royer; R S Nelson; M F Rack; C E Seckman; J H Schwartz
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

4.  Assessment of the safety of selective cyclo-oxygenase-2 inhibitors: where are we in 2003?

Authors:  Yuhong Yuan; Richard H Hunt
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.